LV10461B - Isosteric antiherpes peptide derivatives - Google Patents
Isosteric antiherpes peptide derivatives Download PDFInfo
- Publication number
- LV10461B LV10461B LVP-93-186A LV930186A LV10461B LV 10461 B LV10461 B LV 10461B LV 930186 A LV930186 A LV 930186A LV 10461 B LV10461 B LV 10461B
- Authority
- LV
- Latvia
- Prior art keywords
- tbg
- asp
- cypn
- ch2c
- cme3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84991892A | 1992-03-12 | 1992-03-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10461A LV10461A (lv) | 1995-02-20 |
| LV10461B true LV10461B (en) | 1996-02-20 |
Family
ID=25306833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-186A LV10461B (en) | 1992-03-12 | 1993-03-12 | Isosteric antiherpes peptide derivatives |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0560267B1 (fr) |
| JP (1) | JPH0625131A (fr) |
| KR (1) | KR950700322A (fr) |
| AT (1) | ATE169931T1 (fr) |
| BR (1) | BR9306074A (fr) |
| CA (1) | CA2131186C (fr) |
| CZ (1) | CZ220994A3 (fr) |
| DE (1) | DE69320390T2 (fr) |
| EE (1) | EE9400312A (fr) |
| FI (1) | FI944187A7 (fr) |
| HU (2) | HUT68675A (fr) |
| IL (1) | IL105001A0 (fr) |
| LT (1) | LT3270B (fr) |
| LV (1) | LV10461B (fr) |
| MX (1) | MX9301343A (fr) |
| NO (1) | NO943345L (fr) |
| NZ (1) | NZ251266A (fr) |
| PH (1) | PH30453A (fr) |
| RU (1) | RU94040865A (fr) |
| SG (1) | SG42995A1 (fr) |
| SK (1) | SK107794A3 (fr) |
| TW (1) | TW278080B (fr) |
| WO (1) | WO1993018056A1 (fr) |
| ZA (1) | ZA931745B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846941A (en) * | 1992-03-12 | 1998-12-08 | Boehringer Ingelheim (Canada) Ltd. | Isosteric antiherpes peptide derivatives II |
| CA2095408A1 (fr) * | 1993-05-03 | 1994-11-04 | James Gus Chafouleas | Methode de lutte contre les infections par le virus de l'herpes simplex resistant a l'acyclovir |
| CA2230750C (fr) * | 1994-12-28 | 2002-05-21 | Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee | Composes peptidomimetiques anti-herpes |
| CA2152541C (fr) * | 1995-06-23 | 1998-12-15 | Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee | Inhibiteurs de la ribonucleotide reductase de l'herpes |
| US5948935A (en) * | 1997-01-23 | 1999-09-07 | Boehringer Ingelheim (Canada) Ltd. | Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid |
| DE69943314D1 (de) * | 1998-02-12 | 2011-05-12 | Kapil N Bhalla | Sphingolipid-derivate und verfahren zu deren verwendung |
| CA3112326A1 (fr) | 2018-09-12 | 2020-03-19 | Novartis Ag | Composes antiviraux de pyridopyrazinedione |
| KR20250127350A (ko) | 2019-09-26 | 2025-08-26 | 노파르티스 아게 | 항바이러스성 피라졸로피리디논 화합물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US481432A (en) | 1892-08-23 | soler | ||
| US4795740A (en) | 1986-05-20 | 1989-01-03 | Cohen Eric A | Antiviral peptides and means for treating herpes infections |
| US4837304A (en) | 1987-05-22 | 1989-06-06 | Merck & Co., Inc. | Inhibitor of ribonucleotide reductase |
| US4845195A (en) | 1987-05-22 | 1989-07-04 | Merck & Co., Inc. | Inhibitor of ribonucleotide reductase |
| DE69017113T2 (de) | 1989-07-07 | 1995-08-03 | Bio Mega Boehringer Ingelheim | Pentapeptidderivate, wirksam gegen Herpes, die eine ersetzte Asparaginsäureseitenkette enthalten. |
| CA1340684C (fr) | 1989-07-07 | 1999-07-27 | Pierre Louis Beaulieu | Pentapeptides antiherpetiques |
| CA1340682C (fr) * | 1989-07-07 | 1999-07-27 | Pierre Lavallee | Peptides antiviraux a chaine laterale constituee d'un aminoacide 2-oxoalkyle |
| EP0411333B1 (fr) * | 1989-07-07 | 1995-05-31 | Bio-Mega/Boehringer Ingelheim Research Inc. | Dérivés tetrapeptidiques antiherpes ayant une chaîne latérale d'acide aspartique substituée |
| US5110799A (en) | 1989-07-28 | 1992-05-05 | Merck & Co., Inc. | Antiherpetic agents |
| CA2018801C (fr) | 1990-06-12 | 2000-08-22 | Pierre Louis Beaulieu | Derives peptidiques comprenant une terminaison-n1,4-dioxo-c4 |
| CA2033447C (fr) * | 1990-12-31 | 1999-08-31 | Robert Deziel | Complexe synergique pour le traitement des infections herpetiques |
-
1993
- 1993-03-09 DE DE69320390T patent/DE69320390T2/de not_active Expired - Fee Related
- 1993-03-09 EP EP93103711A patent/EP0560267B1/fr not_active Expired - Lifetime
- 1993-03-09 SG SG1996001914A patent/SG42995A1/en unknown
- 1993-03-09 AT AT93103711T patent/ATE169931T1/de not_active IP Right Cessation
- 1993-03-10 IL IL105001A patent/IL105001A0/xx unknown
- 1993-03-11 PH PH45860A patent/PH30453A/en unknown
- 1993-03-11 ZA ZA931745A patent/ZA931745B/xx unknown
- 1993-03-11 MX MX9301343A patent/MX9301343A/es not_active IP Right Cessation
- 1993-03-11 JP JP5051004A patent/JPH0625131A/ja active Pending
- 1993-03-12 CZ CZ942209A patent/CZ220994A3/cs unknown
- 1993-03-12 WO PCT/CA1993/000095 patent/WO1993018056A1/fr not_active Ceased
- 1993-03-12 FI FI944187A patent/FI944187A7/fi not_active Application Discontinuation
- 1993-03-12 BR BR9306074A patent/BR9306074A/pt not_active Application Discontinuation
- 1993-03-12 LT LTIP408A patent/LT3270B/lt not_active IP Right Cessation
- 1993-03-12 LV LVP-93-186A patent/LV10461B/en unknown
- 1993-03-12 NZ NZ251266A patent/NZ251266A/en unknown
- 1993-03-12 RU RU94040865/04A patent/RU94040865A/ru unknown
- 1993-03-12 HU HU9402593A patent/HUT68675A/hu unknown
- 1993-03-12 SK SK1077-94A patent/SK107794A3/sk unknown
- 1993-03-12 CA CA002131186A patent/CA2131186C/fr not_active Expired - Fee Related
- 1993-03-23 TW TW082102135A patent/TW278080B/zh active
-
1994
- 1994-09-09 NO NO943345A patent/NO943345L/no unknown
- 1994-09-10 KR KR1019940703166A patent/KR950700322A/ko not_active Withdrawn
- 1994-11-23 EE EE9400312A patent/EE9400312A/xx unknown
-
1995
- 1995-06-23 HU HU95P/P00431P patent/HU211926A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9301343A (es) | 1994-01-31 |
| IL105001A0 (en) | 1993-07-08 |
| NZ251266A (en) | 1996-08-27 |
| LTIP408A (en) | 1994-09-25 |
| CA2131186C (fr) | 2000-12-12 |
| ATE169931T1 (de) | 1998-09-15 |
| SK107794A3 (en) | 1995-03-08 |
| NO943345D0 (no) | 1994-09-09 |
| TW278080B (fr) | 1996-06-11 |
| ZA931745B (en) | 1993-09-24 |
| BR9306074A (pt) | 1997-11-18 |
| HUT68675A (en) | 1995-07-28 |
| AU671825B2 (en) | 1996-09-12 |
| CA2131186A1 (fr) | 1993-09-16 |
| HU211926A9 (en) | 1996-01-29 |
| NO943345L (no) | 1994-09-09 |
| EP0560267B1 (fr) | 1998-08-19 |
| AU3880793A (en) | 1993-10-05 |
| EE9400312A (et) | 1996-04-15 |
| PH30453A (en) | 1997-05-28 |
| RU94040865A (ru) | 1996-08-10 |
| FI944187A0 (fi) | 1994-09-12 |
| JPH0625131A (ja) | 1994-02-01 |
| LT3270B (en) | 1995-05-25 |
| DE69320390T2 (de) | 1999-02-11 |
| CZ220994A3 (en) | 1995-09-13 |
| HU9402593D0 (en) | 1994-11-28 |
| FI944187L (fi) | 1994-09-12 |
| KR950700322A (ko) | 1995-01-16 |
| DE69320390D1 (de) | 1998-09-24 |
| FI944187A7 (fi) | 1994-09-12 |
| EP0560267A1 (fr) | 1993-09-15 |
| SG42995A1 (en) | 1997-10-17 |
| LV10461A (lv) | 1995-02-20 |
| WO1993018056A1 (fr) | 1993-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL98443A (en) | Antiherpes peptide derivatives having a 1,4-dioxo-c4n-terminus and pharmaceutical compositions containing them | |
| LV10461B (en) | Isosteric antiherpes peptide derivatives | |
| AU683450B2 (en) | Inhibitors of herpes viral ribonucleotide reductase | |
| US5574015A (en) | Isosteric antiherpes peptide derivatives | |
| AU683465B2 (en) | Method of combating acyclovir-resistant herpes simplex viral infections | |
| EP0560274B1 (fr) | Dérivés de peptides anti-herpès ayant une extrémité N-terminale contenant un groupe ureido | |
| US5830864A (en) | Antiherpes peptide derivatives having a ureido n-terminus | |
| AU671825C (en) | Isosteric antiherpes peptide derivatives | |
| US5846941A (en) | Isosteric antiherpes peptide derivatives II | |
| EP0837845B1 (fr) | Inhibiteurs de la ribonucleotide reductase de l'herpes | |
| EP0800512A1 (fr) | Composes peptidomimetiques anti-herpes | |
| MXPA97010147A (en) | Inhibitors of the ribonucleotido-reductasa deher |